x |
| T12-NEWS reports that the Halozyme Therapeutics' Revenue for its 12 month ended September 30, 2009 Increased by 46.16% |
|
Stock Quote: (NGM:HALO) |
| 11/17/2009 |
|
| 7.44 |
 0.00 |
0.00% |
0 |
|
| T12-NEWS reports that the Halozyme Therapeutics' Revenue for its 12 month ended September 30, 2009 Increased by 46.16% |
|
| Last |
Price Change |
% Chg |
Volume |
|
|
New York, NY, November 17, 2009,T12-NEWS says that trailing twelve month (TTM) Revenue for Halozyme Therapeutics (NASDAQ:HALO) for its twelve months ended September 30, 2009 increased by 46.16% to $10 ... read full story |
|
|
|
|
